## BK: The Bank of New York Mellon Corporation - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.05 indicates fundamental undervaluation. Analyst consensus $134 (+10% upside). Consistent execution (4/4 quarters beat estimates). Caution: overbought RSI (70).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($117.30)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Autonomous Research Adjusts Price Target on Bank of New York Mellon Corp to $137 From $129, Maintains Outperform Rating**
- Source: marketscreener.com | 20260106T120743 | Bullish | Relevance: 100%
- Autonomous Research has increased its price target on Bank of New York Mellon Corp (BK) to $137 from $129, while reiterating an Outperform rating. This adjustment reflects continued analyst confidence in the company's performance, following similar target increases from other firms like Goldman Sachs and BMO Capital. Bank of New York Mellon specializes in asset management and securities services, managing significant assets under custody and administration.

**2. A Look At Bank Of New York Mellon Corporation (BK) Valuation After Recent Share Price Momentum**
- Source: Simply Wall Street | 20260105T183409 | Neutral | Relevance: 100%
- Bank of New York Mellon Corporation (BK) is attracting attention due to its recent share performance, with a 90-day return of 9.45% and a one-year return of 53.53%. While one narrative suggests the stock is slightly undervalued at US$117.04 compared to a fair value of US$119.03, Simply Wall St's DCF model indicates it might be overvalued at US$117.04 against an estimated fair value of US$108.15. Investors are encouraged to assess which valuation approach aligns best with their assumptions about future cash flows and required returns.

**3. Barclays Boosts Bank of New York Mellon (NYSE:BK) Price Target to $143.00**
- Source: MarketBeat | 20260105T151838 | Bullish | Relevance: 100%
- Barclays has increased its price target for Bank of New York Mellon (NYSE:BK) from $120.00 to $143.00, maintaining an "overweight" rating. This new target suggests an 18.12% upside from the stock's previous close, significantly above the consensus target of $113.50 from other analysts. The stock traded up 3.4% to $121.06 midday, reflecting positive market sentiment following the analyst upgrade.

**4. Bank of New York Mellon stock hits all-time high at 119.43 USD**
- Source: Investing.com UK | 20260105T145748 | Bullish | Relevance: 100%
- Bank of New York Mellon (BK) stock has reached an all-time high of $119.43, marking a 55.06% increase over the past year and a 27.93% gain in the last six months. The company boasts 55 consecutive years of dividend payments and 15 years of dividend raises, with recent dividend growth at 12.77%. This robust performance and "GOOD" financial health rating from InvestingPro highlight strong investor confidence and strategic growth.

**5. Davis Capital Management Buys New Position in The Bank of New York Mellon Corporation $BK**
- Source: MarketBeat | 20260104T095249 | Bullish | Relevance: 100%
- Davis Capital Management has acquired a new position in The Bank of New York Mellon Corporation ($BK), purchasing 24,490 shares valued at approximately $2.67 million. This makes BK the 11th largest holding for Davis, comprising about 1.8% of their portfolio. Wall Street sentiment for BK is largely positive, with a "Moderate Buy" consensus rating and an average price target of $111.86.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Barclays | $143 | $120 | +19% |
| 2025-12-17 | Morgan Stanley | $124 | $118 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Barclays | main | Overweight |
| 2025-12-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 10.1% (-0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- Dodge & Cox Inc.: 5.0% (-7.4%)
- FMR, LLC: 5.0% (+6.4%)
- State Street Corpora: 4.7% (-2.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Quality metrics strong (margin 27%). Analyst sentiment positive (2 raises, avg +12%, $134 target (+10%)). Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $85.6B |
| Beta | 1.11 |
| 52W Range | $70.46 - $122.36 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 14.8 |
| Current P/E | 16.4 |
| YoY Growth | 11.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.7% to 2.9% (+2.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 at 1.6% confirms short-term momentum alignment. AM_20 at 3.7% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 70, risk of mean reversion. OFD pattern: -DLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.87% (CS: 66) | Neutral |
| RSI_14 | 70.3 | Overbought |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.037x | Above |
| vs SMA50 | 1.078x | Above |
| vs SMA200 | 1.224x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $121.28
- **Stop Loss:** $117.30 (3.3% risk)
- **Target:** $129.24 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 331
- **Position Value:** $40,143.68
- **Portfolio %:** 40.14%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-13 (Est: $1.99)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.77 | $1.91 | +8.1% |
| 2025Q2 | $1.76 | $1.94 | +10.1% |
| 2025Q1 | $1.49 | $1.58 | +5.9% |
| 2024Q4 | $1.57 | $1.72 | +9.8% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*